What percentage of madecassoside actually works?

Madecassoside is one of the two marker triterpenes (alongside asiaticoside) used to standardize Centella asiatica extract, and it's the compound most consistently cited when a 'cica' or 'centella' product claims soothing or repair benefits. In cultured human dermal fibroblasts, both asiaticoside and madecassoside stimulated type I collagen secretion by roughly 25-30%, and only madecassoside significantly increased type III collagen secretion. Separately, madecassoside reduced pro-inflammatory cytokine (IL-1β) production and blocked NF-κB nuclear translocation in P. acnes-stimulated immune cells, and in keloid-derived fibroblasts it suppressed migration by attenuating p38 MAPK and PI3K/AKT signaling. In a burn-wound mouse model, madecassoside accelerated wound closure and re-epithelialization through antioxidative, collagen-synthesis, and angiogenesis-supporting mechanisms. This is real, mechanistically grounded biology — the honest caveat is that most of it comes from cell culture and animal models, not from isolated topical madecassoside tested on human faces at a stated percentage.

• Study In cultured human dermal fibroblasts, asiaticoside and madecassoside both stimulated type I collagen secretion (a ~25-30% increase), and only madecassoside significantly increased type III collagen secretion. ³
• Study Madecassoside has Cutibacterium (Propionibacterium) acnes-related anti-inflammation and skin-hydration activity, reducing IL-1β production and blocking NF-κB nuclear translocation in vitro. ⁴
• Study Madecassoside suppressed migration of fibroblasts from keloids via attenuation of p38 MAPK and PI3K/AKT signaling pathways. ⁵
• Study Madecassoside isolated from Centella asiatica facilitated burn wound healing in mice, reducing infiltration of inflammatory cells and enhancing epithelialization via dermal fibroblast proliferation, antioxidative activity, collagen synthesis, and angiogenesis. ⁶

The cleanest single-active human data point for topical Centella comes from hand surgery, not cosmetics. A randomized controlled trial of 280 patients (140 per arm) who underwent open carpal tunnel release surgery compared a petroleum-based cream containing 1% Centella asiatica extract against a control cream on the resulting surgical scar, with six-month follow-up. The Centella arm showed significantly better functional scores (QuickDASH 18.54 vs. 28.70, p<0.04) and higher patient satisfaction (VAS) than control. This is a genuine single-active RCT at a stated percentage — the trade-off is that it measures scar/functional outcome after surgery, not everyday facial redness or texture, and it used whole extract rather than isolated madecassoside, so it tells you what a standardized 1% Centella extract can do, not what a specific dose of madecassoside alone delivers.

• Study In a randomized controlled trial of 280 patients (140/140) who underwent open carpal tunnel release surgery, a 1% Centella asiatica extract cream applied to the surgical scar produced significantly better QuickDASH functional scores (18.54 vs 28.70, p<0.04) and higher patient satisfaction (VAS) than control cream at 6-month follow-up. ¹

The only published human RCT that names a specific madecassoside percentage in isolation from whole-extract labeling is a six-month, double-blind trial in 20 female volunteers testing a formulation of 5% vitamin C plus 0.1% madecassoside for photoaged skin. The combination significantly improved wrinkles, skin suppleness, firmness, and roughness, improved hydration, and — on skin biopsy — showed re-appearance of the elastic fiber network, a structural finding rather than just a subjective grading. The catch is unavoidable: this is a two-active formula, and no arm tested 0.1% madecassoside alone against vehicle. You cannot credit madecassoside for the full effect when 5% vitamin C, itself independently well-evidenced for photoaging, is doing part of the work. Treat 0.1% as the one real percentage on record for madecassoside specifically, not as a validated standalone dose.

• Study A double-blind RCT in 20 female volunteers testing a topical formulation of 5% ascorbic acid plus 0.1% madecassoside over 6 months found significant improvement in wrinkles, suppleness, firmness, roughness, and hydration of photoaged skin, with skin biopsy showing re-appearance of the elastic fiber network. ²

One honest caveat This is a combination formula (5% vitamin C + 0.1% madecassoside), not madecassoside tested alone. The improvement cannot be attributed to madecassoside specifically — vitamin C at 5% has independent photoaging evidence of its own. No dose-ranging arm (e.g., 0.05% vs 0.1% vs 0.2% madecassoside) has been published.

The overwhelming majority of 'centella,' 'cica,' and 'madecassoside' products on the market disclose that the ingredient is present, not how much of it is present, and disclose extract percentage (if at all) rather than triterpene content. SKIN1004's Madagascar Centella Asiatica 100 Ampoule and COSRX's Alpha Arbutin 2% Discoloration Serum (which lists madecassoside alongside its disclosed 2% alpha-arbutin) both include Centella-derived actives with the concentration of the active triterpene undisclosed — which is the norm, not the exception, in this category. Because centella's bioactivity is pinned to its triterpene content, and madecassoside is one of two marker compounds used to standardize the plant, two 'centella' products can contain very different amounts of active triterpene despite similar-looking labels. Until brands start disclosing standardized triterpene content (the way they'd disclose niacinamide or vitamin C percentage), 'what percentage of madecassoside is in this' is often simply unanswerable from the label — and no published research has run the head-to-head dose-ranging study that would tell you what percentage to look for even if it were disclosed.

One honest caveat No study has compared two or more distinct madecassoside percentages head-to-head. The 1% and 0.1% figures above are the only two human RCT percentages on record for topical Centella/madecassoside, and neither defines a floor, ceiling, or dose-response curve.

What percentage of madecassoside is effective?

There's no validated answer. The only published human RCT using a specific madecassoside percentage tested 0.1% combined with 5% vitamin C for photoaging (PMID:18503551) — a real result, but confounded by the vitamin C. The strongest single-active human data uses 1% whole Centella asiatica extract, not isolated madecassoside, in a 280-patient surgical scar trial (PMID:36918311). No study has compared different madecassoside percentages against each other. ²¹

Is 1% Centella asiatica extract proven to work?

For scar outcomes, yes, in one large trial: a randomized controlled trial of 280 patients found 1% Centella asiatica extract cream produced significantly better functional scores and patient satisfaction than control cream after open carpal tunnel release surgery, at 6-month follow-up (PMID:36918311). That's a genuine single-active RCT at a stated percentage — but it measured post-surgical scarring, not everyday facial skin concerns, and used whole extract rather than isolated triterpenes. ¹

Why don't centella and cica products list a madecassoside percentage?

Because centella's bioactivity is tied to its triterpene content (asiaticoside, madecassoside, asiatic acid, madecassic acid), and most brands disclose extract presence rather than standardized triterpene dose. Two 'centella' products — including well-known ones like SKIN1004's Madagascar Centella Asiatica 100 Ampoule — can contain very different amounts of active triterpene despite similar labeling. Until standardized triterpene disclosure becomes common, the percentage question often can't be answered from the label alone.

Does madecassoside actually stimulate collagen?

In cell culture, yes: madecassoside and asiaticoside both increased type I collagen secretion by roughly 25-30% in cultured human dermal fibroblasts, and madecassoside alone also significantly increased type III collagen (PMID:7741425). That's real mechanistic evidence, but it's an in-vitro finding, not a measurement from a specific topical percentage applied to human skin — treat it as supporting plausibility for the 1% and 0.1% clinical results above, not as proof at any particular dose. ³

Is there a 'too low' or 'too high' percentage of madecassoside?

That can't be answered honestly. No published study has tested a dose-ranging series of madecassoside percentages, so there is no established floor below which it stops working or ceiling above which more doesn't help. The two data points on record (0.1% and 1% whole extract) are both single concentrations tested against a comparator, not points on a validated dose-response curve.

1. 1

   The effect of Centella Asiatica cream on scar development in patients who underwent open carpal tunnel release surgery

   Balevi M, Balevi A · Journal of Hand Therapy 36(4):962-966 · 2023

2. 2

   Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with ascorbic acid and madecassoside in photoaged human skin

   Haftek M, Mac-Mary S, Le Bitoux MA, Creidi P, Seite S, Rougier A, Humbert P · Experimental Dermatology 17(11):946-52 · 2008

3. 3

   [Comparative activity of asiaticoside and madecassoside on type I and III collagen synthesis by cultured human fibroblasts]

   Bonte F, Dumas M, Chaudagne C, Meybeck A · Ann Pharm Fr 53(1):38-42 · 1995

4. 4

   Propionibacterium acnes related anti-inflammation and skin hydration activities of madecassoside, a pentacyclic triterpene saponin from Centella asiatica

   Shen X, Guo M, Yu H, Liu D, Lu Z, Lu Y · Biosci Biotechnol Biochem 83(3):561-568 · 2019

5. 5

   Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways

   Song J, Xu H, Lu Q, Xu Z, Bian D, Xia Y, Wei Z, Gong Z, Dai Y · Burns 38(5):677-84 · 2012

6. 6

   Madecassoside isolated from Centella asiatica herbs facilitates burn wound healing in mice

   Liu M, Dai Y, Li Y, et al · Planta Med 74(8):809-15 · 2008